{
    "Systemic Therapy for Advanced or Metastatic Disease": {
        "Sensitizing EGFR Mutation Positive": {
            "Osimertinib": "Progression (See NSCL-20)",
            "Erlotinib": "Progression (See NSCL-20)",
            "Afatinib": "Progression (See NSCL-20)",
            "Gefitinib": "Progression (See NSCL-20)",
            "Dacomitinib": "Progression (See NSCL-20)"
        }
    },
    "footnotes": {
        "1": "See Principles of Systemic Therapy (NSCL-F)."
    }
}